Company · CIK 0001672619 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Enliven Therapeutics, Inc. · ELVN
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 17, 2026 SForm 4 → | Sep 21, 5:23 pm EDT | Benjamin HohlCHIEF FINANCIAL OFFICER | 6,018 | $50.35 | $303,003 | 38,000 | −13.7% | 10b5-1 |
| Sep 17, 2026 MForm 4 → | Sep 21, 5:23 pm EDT | Benjamin HohlCHIEF FINANCIAL OFFICER | 3,982 | $14.85 | $59,133 | 44,018 | — | 10b5-1 |
| Sep 17, 2026 SForm 4 → | Sep 21, 5:22 pm EDT | Helen Louise CollinsCHIEF MEDICAL OFFICER | 5,000 | $50.35 | $251,754 | 25,000 | −16.7% | 10b5-1 |
| Sep 17, 2026 MForm 4 → | Sep 21, 5:22 pm EDT | Helen Louise CollinsCHIEF MEDICAL OFFICER | 5,000 | $2.48 | $12,400 | 30,000 | — | 10b5-1 |
| Aug 17, 2026 SForm 4 → | Aug 19, 4:17 pm EDT | Benjamin HohlCHIEF FINANCIAL OFFICER | 6,018 | $58.58 | $352,551 | 40,036 | −13.1% | 10b5-1 |
| Aug 17, 2026 SForm 4 → | Aug 19, 4:16 pm EDT | Helen Louise CollinsCHIEF MEDICAL OFFICER | 5,000 | $58.59 | $292,931 | 25,000 | −16.7% | 10b5-1 |
| Aug 17, 2026 MForm 4 → | Aug 19, 4:16 pm EDT | Helen Louise CollinsCHIEF MEDICAL OFFICER | 5,000 | $2.48 | $12,400 | 30,000 | — | 10b5-1 |
| Aug 4, 2026 SForm 4 → | Aug 6, 8:18 pm EDT | Mika K DerynckDirector | 158,795 | $60.21 | $9,561,587 | 0 | −100% | 10b5-1 |
| Aug 4, 2026 MForm 4 → | Aug 6, 8:18 pm EDT | Mika K DerynckDirector | 158,795 | $10.84 | $1,720,967 | 158,795 | — | 10b5-1 |
| Jul 17, 2026 SForm 4 → | Jul 21, 5:24 pm EDT | Benjamin HohlCHIEF FINANCIAL OFFICER | 6,018 | $52.64 | $316,780 | 46,054 | −11.6% | 10b5-1 |
| Jul 17, 2026 MForm 4 → | Jul 21, 5:24 pm EDT | Benjamin HohlCHIEF FINANCIAL OFFICER | 1,072 | $2.48 | $2,659 | 52,072 | — | 10b5-1 |
| Jul 17, 2026 SForm 4 → | Jul 21, 5:23 pm EDT | Helen Louise CollinsCHIEF MEDICAL OFFICER | 5,000 | $52.67 | $263,373 | 25,000 | −16.7% | 10b5-1 |
| Jul 17, 2026 MForm 4 → | Jul 21, 5:23 pm EDT | Helen Louise CollinsCHIEF MEDICAL OFFICER | 5,000 | $2.48 | $12,400 | 30,000 | — | 10b5-1 |
| Jul 6, 2026 SForm 4 → | Jul 8, 5:15 pm EDT | Lori Anne KunkelDirector | 10,000 | $50.49 | $504,903 | 41,884 | −19.3% | 10b5-1 |
| Jun 22, 2026 SForm 4 → | Jun 24, 7:19 pm EDT | ORBIMED ADVISORS LLC +210% Owner | 860,123 | $45.36 | $39,014,046 | 6,555,102 | −11.6% | |
| Jun 17, 2026 SForm 4 → | Jun 22, 5:13 pm EDT | Benjamin HohlCHIEF FINANCIAL OFFICER | 6,018 | $43.80 | $263,577 | 51,000 | −10.6% | 10b5-1 |
| Jun 17, 2026 MForm 4 → | Jun 22, 5:13 pm EDT | Benjamin HohlCHIEF FINANCIAL OFFICER | 6,018 | $2.48 | $14,925 | 57,018 | — | 10b5-1 |
| Jun 17, 2026 SForm 4 → | Jun 22, 5:11 pm EDT | Helen Louise CollinsCHIEF MEDICAL OFFICER | 5,000 | $43.80 | $219,017 | 25,000 | −16.7% | 10b5-1 |
| Jun 17, 2026 MForm 4 → | Jun 22, 5:11 pm EDT | Helen Louise CollinsCHIEF MEDICAL OFFICER | 5,000 | $2.48 | $12,400 | 30,000 | — | 10b5-1 |
| Jun 15, 2026 SForm 4 → | Jun 17, 7:45 pm EDT | ORBIMED ADVISORS LLC +210% Owner | 281,408 | $45.02 | $12,668,988 | 7,388,902 | −3.67% | |
| Jun 5, 2026 SForm 4 → | Jun 9, 4:49 pm EDT | Lori Anne KunkelDirector | 10,000 | $34.54 | $345,351 | 51,884 | −16.2% | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 17, 2026 MForm 4 → | Sep 21, 5:23 pm EDT | Benjamin HohlCHIEF FINANCIAL OFFICER | 3,982 | — | — | 181,018 | — | 10b5-1 |
| Sep 17, 2026 MForm 4 → | Sep 21, 5:22 pm EDT | Helen Louise CollinsCHIEF MEDICAL OFFICER | 5,000 | — | — | 106,268 | — | 10b5-1 |
| Aug 17, 2026 MForm 4 → | Aug 19, 4:16 pm EDT | Helen Louise CollinsCHIEF MEDICAL OFFICER | 5,000 | — | — | 111,268 | — | 10b5-1 |
| Aug 4, 2026 MForm 4 → | Aug 6, 8:18 pm EDT | Mika K DerynckDirector | 158,795 | — | — | 0 | — | 10b5-1 |
| Jul 17, 2026 MForm 4 → | Jul 21, 5:24 pm EDT | Benjamin HohlCHIEF FINANCIAL OFFICER | 1,072 | — | — | 84,966 | — | 10b5-1 |
| Jul 17, 2026 MForm 4 → | Jul 21, 5:23 pm EDT | Helen Louise CollinsCHIEF MEDICAL OFFICER | 5,000 | — | — | 116,268 | — | 10b5-1 |
| Jun 17, 2026 MForm 4 → | Jun 22, 5:13 pm EDT | Benjamin HohlCHIEF FINANCIAL OFFICER | 6,018 | — | — | 86,038 | — | 10b5-1 |
| Jun 17, 2026 MForm 4 → | Jun 22, 5:11 pm EDT | Helen Louise CollinsCHIEF MEDICAL OFFICER | 5,000 | — | — | 121,268 | — | 10b5-1 |